Researchers have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination. In this process, they have also discovered that some SARS-CoV-2 antibodies bind to tissue samples from various organs, which could potentially trigger undesired side effects.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/09/200924135401.htm
No comments:
Post a Comment